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The scope of this project is to develop adenoviral vectors that are capable of mediating gene expression specifically in prostate and prostate cancer cells. We propose to incorporate a highly potent and specific two-step transcriptional amplification (TSTA) system to mediate prostate-targeted gene expression in our vectors. In diagnostic applications, this targeted vector will be utilized to express optical reporter luciferase gene. The hypothesis is that administration of this imaging reporter virus could illuminate prostate metastatic cells in living animals. Our intention was to extend this prostate-specific molecular imaging approach to the high-energy radionuclide Positron Emission Tomography (PET) such that future clinical diagnostic applications can be developed. In a second therapeutic approach, the TSTA system is employed to regulate viral replication, which leads to specific lysis of prostate tumor cells. Creation of consistent and easy to follow metastatic prostate cancer models will be very useful towards the evaluation of the proposed vector-based diagnostic and therapeutic approaches.
Body:
Task IA: Determine sensitivity of vector-based imaging. Findings relevant to this task were reported in two manuscripts. Targeted Suicide Gene Therapy Achieved Effective Tumor Destruction While Safeguarding Against Systemic Toxicity. Submitted. The results from these two manuscripts concluded that the prostate-specific TSTA adenoviral vector can produce robust PET imaging signals in androgen-independent tumors ( Figure 1 ) and mediate targeted cytotoxic effects in prostate tumors. As PET imaging is a clinical relevant imaging modality, these results support the translatability of our approach to future clinical diagnostic applications. tumor cells by transducing with a firefly luciferaseexpressing lentiviral vector, we were able to monitor the metastatic events by optical CCD imaging (Adams et al. Nat Med 8:891, 2002 
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Task 2A: Generation of therapeutic direction expression of two genes can be regulated by the centrally located Ga14-VP16 activators, we have created a virus that expresses firefly luciferase (FL) and herpes simplex thymidine kinase (TK) gene in divergent orientation (Figure 4 ). Co-infection of this bi-directional reporter virus with a Gal4-VP16 activator-expressing virus (AdBC-VP2, 3) resulted in expression of both FL and TK proteins, which can be detected by optical and PET imaging simultaneously (Figure 4) . Our group has shown that this bi-directional TSTA expression system was feasible in DNA a plasmid transfection study (Ray et al. below) .
Applying this bi-directional expression approach, we demonstrated that in the designed oncolytic viral constructs both E1A and E1B gene were expressed in an androgen regulated manner. Moreover, viral replication can be induced specifically ( Figure 5 ). These results supported that the feasibility of our oncolytic virus to mediate viral replication and, hence, tumor cell tumor models are being established. vasculatures would enable us to better delineate the path of metastasis and design optimal diagnostic imaging strategies to detect metastases.
3.
Functionality of the bi-directional TSTA mediated simultaneous expression of two genes was established.
4.
Feasibility of the bi-directional oncolytic virus was also supported. 
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Conclusions:
We have demonstrated that the TSTA approach can greatly augment prostatespecific gene expression. Imaging and therapeutic TSTA adenoviral vectors mediate targeted gene expression in animal prostate tumor models. The feasibility and functionality of prostate-specific oncolytic adenovirus regulated by the bi-directional TSTA system has been established. We have also generated metastatic prostate cancer models marked with sensitive optical reporter gene. These models will facilitate the investigation of tumor biology and serve as excellent models to investigate our vector-based imaging and oncolytic therapeutic strategy for metastatic disease. 
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ABSTRACT
Molecular imaging methods have previously been employed to image tissue-specific reporter gene expression by a two-step transcriptional amplification (TSTA) strategy. We have now developed a new bidirectional vector system, based on the TSTA strategy, that can simultaneously amplify expression for both a target gene and a reporter gene, using a relatively weak promoter. We used the synthetic Renilla luciferase (hrl) and firefly luciferase (fl) reporter genes to validate the system in cell cultures and in living mice. When mammalian cells were transiently cotransfected with the GAL4-responsive bidirectional reporter vector and various doses of the activator plasmid encoding the GAL4-VP16 fusion protein, pSV40-GAL4-VP16, a high correlation (r 2 = 0.95) was observed between the expression levels of both reporter genes. Good correlations (r 2 = 0.82 and 0.66, respectively) were also observed in vivo when the transiently transfected cells were implanted subcutaneously in mice or when the two plasmids were delivered by hydrodynamic injection and imaged. This work establishes a novel bidirectional vector approach utilizing the TSTA strategy for both target and reporter gene amplification. This validated approach should prove useful for the development of novel gene therapy vectors, as well as for transgenic models, allowing noninvasive imaging for indirect monitoring and amplification of target gene expression.
OVERVIEW SUMMARY
therapeutic gene simply by studying the highly correlated expression of the tightly coupled reporter gene. Tissue-specific promoters frequently used for tissue-specific delivery of therapeutic genes in gene therapy applications are limited by their weak transcriptional ability. To over-INTRODUCTION come this drawback the two-step transcriptional amplification (TSTA) strategy was designed to enhance the promoter (NONVENTIONAL NONINVASIVE CANCER THERAPY is often hamstrengths of such weak tissue-specific promoters. Here, we C.,pered by a lack of tumor specificity that frequently culmireport on the engineering, functional characterization, and nates in unwanted severe adverse effects, thereby limiting therin vivo application of a bidirectional TSTA system that will apeutic doses and rendering the malignant lesions resilient to allow us to simultaneously amplify the expression of a ther-treatment (Nettelbeck et al., 1998 (Nettelbeck et al., , 2000 . Gene therapy conapeutic gene and that of a tightly coupled reporter gene. We tinues to be investigated as a potential alternative to the drawdemonstrate that such a bidirectional TSTA system will also backs of traditional cancer therapy. Thus the goal is to achieve be helpful in quantifying the amplified expression of the high levels of transcription of a transgene in the desired cell Ray et al., 2003) . Our laboratory has successfully used both J7 even when suitably delivered to the target site, are often unable and synthetic Renilla luciferase (hrl) as bioluminescence optito achieve therapeutic levels of the protein transcribed from the cal reporter genes to study gene expression in small animals. therapeutic gene (TG). Thus it became imperative to design We have also reported that bothfl and hrl can be imaged in the strategies to enhance promoter strength, while maintaining same animal and that they present different light production kispecificity, of these weak tissue-specific promoters (Nettelbeck netics without any substrate cross-reactivity (Bhaumik and  et al., 2000) . Gambhir, 2002a,b) . Several strategies have been successfully implemented so far.
Gene expression can be imaged directly if the transgene or These include (1) designing a minimal promoter by eliminating therapeutic gene (TG) is also an imaging reporter gene (RG), from a natural promoter all the other elements that do not con-for example, HSVI-tk or the mutant thymidine kinase (HSVItribute to promoter strength, (2) designing promoters containing sr39tk) gene, whose protein product HSV I thymidine kinase activated point mutations, (3) constructing chimeric promoters (HSVI-TK/SR39TK) can trap various radiolabeled substrates by combining the transcriptional regulatory elements from dif-in cells and hence can be detected by PET/SPECT (Gambhir et ferent promoters specific for the same tissue, (4) The RTA approach, also referred to as the two-step tran-that can be radiolabeled and used to generate images that descriptional amplification (TSTA) approach, has been effectively fine the magnitude of gene expression. Thus general strategies used to enhance the transcriptional ability of tissue-specific pro-have been developed and validated to link the expression of the moters in both cell culture and in living animals. In this approach TG to a PET or optical RG and to track in vivo expression of the promoter drives the production of the potent GAL4-VP16 the TG indirectly by imaging the RG. Linking the expression transcriptional activator, encoded by the "activator" plasmid. This of the TG to the RG can be achieved through a variety of difchimeric transcription factor, consisting of the highly potent ac-ferent molecular constructs (Ray et al., 2001 ; Sundaresan and tivation domain of the herpes simplex virus type I (HSV1) VPI 6 Gambhir, 2002) . One approach is to clone both genes, one imimmediate-early trans-activator fused to the yeast GAL4-DNA-mediately following the other (with or without a short spacer) binding domain, in turn acts on a second expression plasmid en- (Ray et al., 2003) , downstream of a single promoter. A single coding the reporter/therapeutic proteins through a GALA-re-mRNA strand carrying the coding regions of both genes will sponsive minimal promoter bearing multiple tandem copies of be transcribed from this construct and will encode a fusion prothe 17-bp GAL4-binding sites (G5) placed upstream from the tein. This approach requires that the function of the reporter progenes of interest. ). Because the promoters are identianimals. These studies validated the ability of the TSTA system cal, theoretically, the two separate mRNAs and proteins that are to enhance the transcriptional ability of a weak tissue-specific produced should be correlated. A simpler method is to coadpromoter, the prostate-specific antigen enhancer/promoter (PSE). minister two identical vectors, one carrying the TG and the other The system was also valuable in demonstrating androgen-re-the RG. Our laboratory has demonstrated that it is possible to sponsive activity in prostate cancer cells ( responsive promoter system. One or both of the reporter genes Earlier, Baron et al. (1995) constructed a tetracycline-in-can be changed to a therapeutic gene of interest. Our results ducible novel vector system in which a single bidirectional show that two optical reporter genes encoding firefly lucifertetracycline-inducible promoter can be used to control the exase (FL) and synthetic Renilla luciferase (hRL) are indeed pression of any pair of genes in a correlated, dose-dependent coregulated in a quantitative manner by means of this stratmanner. We applied this bidirectional strategy and obtained egy, both in cell culture as well as in living animals imaged highly correlated expression of two PET reporter genes in liv-with an optical system. ing subjects (Sun et al., 2001 ).
In the current study, our objective was to develop a new bidirectional vector system, based on the TSTA/RTA model, MATERIALS AND METHODS that can amplify the expression of both a TG and a RG simultaneously (Fig. I ). This system should help in determin-Chemicals ing the spatial location(s) and level of expression of the target gene with the help of the highly correlated expression of Dulbecco's modified Eagle's medium (DMEM) was purthe tightly coupled reporter gene, which can be imaged non-chased from GIBCO-BRL (Grand Island, NY). A luciferase asinvasively. The system consists of two components: (1) an ac-say kit was purchased from Promega (Madison, WI). D-Lutivator plasmid encoding the GAL4-VP1 6 trans-activator pro-ciferin potassium salt, a substrate for FL, was obtained from Xenogen (Alameda, CA). Coelenterazine, the substrate for hRL, Hercules, CA) in a DU-50 spectrophotometer (Beckman Coulwas purchased from Biotium (Hayward, CA).
ter, Fullerton, CA) and the luminescence results are reported as relative light units (RLU) per microgram of protein.
Cell culture
FL assays were carried on with a luciferase assay kit from N,, cells (mouse neuroblastoma), 293T cells (human kid-Promega. Renilla luciferase assays were performed as described ney), and HeLa cells (human cervical carcinoma) were grown previously (Bhaumik and Gambhir, 2002a) . in DMEM high-glucose supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin solution.
Preparation of coelenterazine and D-luciferin
A stock solution of coelenterazine in methanol (2 mg/ml) Construction of plasmids/vectors was further diluted with phosphate-buffered saline (PBS). A 15-
The activator plasmid pSP72-SV40-GAL4-VP16 was con-mg/mI stock solution of D-luciferin in PBS was filtered through structed as described earlier ( , using a 5'-CD-1 mice more than 6 weeks of age. Both plasmids, in difend primer with an SluT site attached (AATTAGGCCTAAferent proportions (as described in Results), were mixed thor-TTCTCGAGATTTAGGTGACACTATAGAAT) and a 3'-end oughly with 2 ml of PBS and kept in ice. The whole volume primer with an Nhel site attached (AATTGCTAGCACACwas then rapidly (within 2-3 sec) injected (hydrodynamic in-CACTCGACACGGCACC). The 5'-end primer also encoded a jection) into the tail vein of each animal. Animals were subunique XhoT site just following the Stul site. The PCR fragment jected to bioluminescence imaging 6 and 24 hr postinjection. was subsequently digested with StuI and Nhel and cloned into For imaging hrl gene expression 100 pA of the coelenterazine the PBIL vector. The second E4TATA minimal promoter was (20 jg for xenograft studies and 40 /jg for naked DNA experthen inserted in the (-) strand preceding theft gene in the veciments) was injected via the tail vein approximately 10 sec betor. The E4TATA sequence was PCR amplified from the fore imaging, whereas to imageft gene expression 200 A.l of DpSP72-E4TATA-CAT plasmid (Iyer et al., 2001), using an up-luciferin (3 mg) was injected intraperitoneally 10 min before stream primer with an XhoI site (AATTCTCGAGGGATCCimaging. All mice were imaged with a cooled charge-coupled CCAGTCCTATATATACT) and a 3'-end primer with an SacTl device (CCD) camera (IVIS; Xenogen) and photons emitted site (AATTCCGCGGACACCACTCGACACGGCACC). The from cells implanted in the mice were collected and integrated E4T-G5-E4T cassette completely replaced the TRE promoter for a period of 1 min. Images were obtained with Living Imelement in the original PBIL vector, age software (Xenogen) and IGOR image analysis software For the sake of convenience the bidirectional reporter tern-(Wavemetrics, Lake Oswego, OR). Imaging was continued unplate with ft and hrl is abbreviated asft-G5-hrl, the trans-acti-til the hRL signal dropped beyond detectable limits (-2 hr). vator plasmid pSV4O-GAL4-VPl6 is VPl6, and the unidirec-The animals were then injected intraperitoneally with 200 ill tional TSTA system is G5fl.
of D-luciferin stock solution and each animal was imaged for 15 min, with 1 min of acquisition each time.
Cell transfections and enzyme assays
For quantification, regions of interest (ROls) were drawn Cells were plated in 12-well plates in DMEM containing over the sites of implantation and maximum photons/sec/cm 2 / 10% FBS. Transient transfections were performed 36 hr later steradian was obtained. with Superfect transfection reagent. Each transfection mix contained different dose combinations of the reporter plasmid fl-Statistical testing G5-hrl and the activator plasmid VP16. After 24 hr of incubaLinear regression analysis was performed to assess the linear tion the cells were harvested and the cell lysate was used for relationship between two variables. The strength of correlation enzyme assays.
between them was quantified in terms of the square of the Pearson correlation coefficient (1" 2 ). The significance of correlation
Lucifrerase assays
was obtained by performing the Student t test against the null hyAll bioluminescence assays were performed in a TD 20/20 pothesis that the correlation coefficient (r) is zero. Values of p < luminometer (Turner Designs, Sunnyvale, CA) with an inte-0.05 were considered statistically significant. All cell culture and gration time of 10 sec. The protein content of the cell lysates mouse group comparisons were performed with a Student t test. was determined with a Bio-Rad protein assay system (Bio-Rad, Values of p --0.05 were considered statistically significant.
RESULTS
transgene, using the current strategy, we cotransfected N2a (0-0.75 Ag/well), HeLa (0-0.75 pg/well), and 293T (0-0.8 /g/well) cells A GAL4-responsive bidirectional strategy can anplify with various doses of the activator plasmid and a constant dose the expression of two independent reporter genes in (0.5 j.g/well) of the reporter plasmid. After 24 hr of transfection transiently transfected cells the cell lysates were collected and assayed for FL and hRL enTo determine, in cell culture, whether this novel strategy has zyme activities. Figure 3C illustrates correlation between the acthepotermn etia cel a l t, wthe r expressionofbothi reovtraterge as tivities of the two luciferases stated as average relative light units the potential to amplify the expression of both reporter genes si-high multaneously, N2, cells were transiently cotransfected in 12-well (rLeramio gra o proten Regei an alyis so hig plates with the activator (VPI16) and the reporter (fl-G5-hrl) plas-cells. High correlations a re also seen in the case of HeLa (r 2 = mids in a 1:1 ratio and the cell lysates were assayed 24 hr after c. High celas are a nit seofe). transfection. Robust expressions of both reporter genes were obtained in the presence of the GAL4-VPI6 fusion protein com-Expression of both reporter genes increases linearly pared to cells transfected with the same amount of reporter plas-and in a highly correlated fashion in cells transfected mid alone ( Fig. 2A and B) . Firefly luciferase protein activity is with various doses of the reporter plasmid while about 2000-fold higher than in mock-transfected cells and cells keeping the dose of the activator plasmid constant transfected with activator plasmid only, and about 300-fold higher than in cells transfected with only the reporter plasmid. Similarly, To see whether the results were reproducible if the dose of there is a 500-and 600-fold gain in expression of the hrl gene in the reporter component of the system was changed while keepcells cotransfected with both plasmids compared with cells car-ing the activator component constant, we repeated the transrying only the activator plasmid or the reporter plasmid, respec-fection studies with multiple doses of the reporter plasmid tively, and a 700-fold gain compared with mock-transfected cells. (0-0.75 /g/well) while the amount of the activator plasmid was This result illustrates, primarily, that this novel vector will allow kept constant at 0.5 jg/well in N 2 . cells. The FL and hRL acus to drive the expression of both genes simultaneously in the presence of GALA-VP16. When CMV-hrl is compared with the bidirectional system, there is 2-fold lower hRL activity in the case is kept constant 60000 S. 50000
To confirm that the levels of expression of the reporter genes M 40000 increase in accordance with increasing levels of the activator pro- (Fig. 4C) . The results were ous doses of fl-G5-hrl and a constant dose of VP16. The also reproducible in both HeLa and 293T cells (r 2 = 0.95 and correlation is r A ciferin. There is a linear increase in the expression levels of both genes across mice for the dose range tested (Fig. 5A ). Fur-
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'thermore, the expression levels of both reporter genes, mea- Correlation of fi and hrl gene expression from mice optically sites in each of three male nude mice. The mice were then imaged after the injection of 10 tLg each of the activator plasscanned with the cooled CCD camera to image the activities of mid (VP1 6) and the reporter plasmid (fl-G5-hrl). Shown is a the luciferases from each site. The mice were first scanned af-plot of hRL activity versus FL activity, expressed as maximum ter tail vein injection of coelenterazine. Five hours later the mice photons/cm 2 /sec/sr, obtained from same-sized ROls drawn over were scanned again after an intraperitoneal injection of D-lu-the liver region on the mouse images (r 2 = 0.66, n = II mice).
to transfect the liver hepatocytes in vivo with high efficiency to the liver can be achieved via a hydrodynamically based pro- (Zhang et al., 1999) . We wanted to test whether our system cedure involving rapid tail vein injection of a large volume of would be able to produce detectable expression of the two re-DNA solution (Liu and Knapp, 2001; Herweijer and Wolff, porter genes and also retain the high degree of correlation be-2003). This method is being widely utilized by gene therapy tween the gene expression levels in the hepatocytes transfected researchers to evaluate the therapeutic activities of various in vivo by this technique. Indeed, we could detect robust ex-genes (Zhang et al., 2004) . We decided to adopt this method to pressions of both fi and hrl reporter genes in the liver regions transfect hepatocytes in vivo with both activator and reporter of the animals within 6 hr of hydrodynamic injection and ex-plasmids and then study whether the correlation was still mainpression was still high even 24 hr after the injection (Fig. 6A) . tamned between the levels of expression of the two genes. We Most importantly, the level of expression of the hrl gene is obtained a good level of correlation between the two reporter also well correlated (r 2 =0.66) with that of thefl gene in livgenes (r 2 = 0.66), similar to what was seen in the xenograft ing mice (n = 11) (Fig. 6B) . studies. These results support the robustness of our system. However, in contrast to the xenograft studies, in the naked DNA experiments we had to administer a higher dose of coelenterazine to obtain a detectable signal for the hrl reporter gene. This DISCUSSION was expected because Renilla luciferase is known to produce blue-shifted light (475 nm) that is largely attenuated while trayThis article reports initial results from experiments in which eling from a deep tissue environment like the liver. Apart from a novel GAL4-responsive bidirectional vector was used to am-this there could be other parameters that regulate the delivery plify the expression of two reporter genes simultaneously both of the substrate coelenterazine to the transfected hepatocytes, in cell culture and in living animals. This system should help such as the hepatic circulation and the presence of P-glycoproto amplify the expression of a gene of interest from a weak tisteins (Ros et al., Pichler et al., 2004) . All these factors sue-specific promoter and to determine the spatial location and can also be influential in achieving a lower correlation cornlevel of expression of the target gene repeatedly, with the help pared with subcutaneous tumor studies, in which the source of of the highly correlated expression of a tightly coupled reporter light has a superficial location. gene. This approach can be made fully quantitative and tomo-
The bidirectional system showed a 3-to 4-fold lower exgraphic by simply replacing the optical reporter gene with a pression of thefl gene when compared with a well-established PET reporter gene.
reporter system, CMV-fl, and a 2-to 3-fold lower signal of the We have previously demonstrated that the TSTA strategy forward hrl gene when compared with CMV-hrl. An earlier can be used to amplify the expression of a single reporter gene TSTA system also showed a 2-to 3-fold lower signal from a from a weak tissue-specific promoter in a prostate-specific man-SV40-GAL4- nal from the forward hrl gene when compared with CMV-hrl Accordingly, we decided to design a bidirectional system based is in accordance with previous results. Previous studies have on the TSTA model that will link a therapeutic gene with an validated that 5XGAL4-binding sites are optimal for one proimaging reporter gene, so that, as stated previously, by simply moter (Emami and Carey, 1992; Iyer et al., 2001; Zhang et al., studying the reporter gene noninvasively we can estimate the 2002). Thus it could be possible that the inclusion of an addimagnitude of expression of our target gene of interest and also tional promoter might compete with the available GAL4-VPI6 monitor its location. Such a system may also be useful in transactivator proteins, thereby resulting in a reduction of overall acgenic animal applications, where the expression of the gene of tivities of both promoters. However, we are unable to explain interest can be repeatedly monitored in an intact animal.
the phenomenon causing a greater attenuation of the expression •In the present study we observed that expression from both level of the reverse gene. On the basis of other studies (Ross coding regions was significantly elevated and retained a high et al., 2000; Dion and Coulombe, 2003) it seems unlikely that level of correlation. Our data demonstrate that the hRL signal this effect is related to the orientation of the GAL4-DNA-bindresulting from translation of the forward hrl gene in the bidiing domains. It has been observed that the ability of GAL4-rectional reporter vector can be used to quantify the level of ex-VP 16 to activate transcription varies 1-to 2-fold with 2-to 8-pression of the fi gene in living animals. However, there was bp variations in the spatial positioning of the DNA-bound apparently a significant attenuation of the fi gene placed in a activation domain from the TATA box of the promoter (Ross reverse orientation to the GAL4-binding sites in the vector. De-et al., 2000) . Thus it is possible that slight dissimilarities in the spite this, we could observe robust signal from thefl gene both spacer distances between the individual E4TATA minimal proin cell culture and in vivo. Most importantly, we also obtained mooters and the GAL4-binding sites in the reporter plasmid can a high correlation between the expression levels of the two re-impart differential transcriptional abilities to the promoters, reporter genes both in cell culture (r 2 = 0.95) and in living anisulting in turn in differential expression of the genes they actimals (r 2 = 0.82 and 0.66), using bioluminescence imaging. vate. Uneven spacer distances between the coding sequences of The naked DNA experiments were performed to test the ef-the two genes and their minimal promoters may also cause this ficacy of the system developed in a real gene therapy applicaeffect. In our vector system the reverse fi gene is 30 bp away tion, in which the different components of this system will be from its E4TATA minimal promoter, whereas the forward hrl delivered in vivo by means of different nonviral or viral vecgene is only 10 bp away. We are currently trying to test these tors andwill be required to transfect the cells of the animal in possibilities by simply switching the positions of the two genes situ. Earlier studies have shown that efficient plasmid delivery and repeating the experiments with the new reporter vector. Paulmurugan and Gambsystem that can successfully achieve amplification of two in-hir, 2003), and developing model gene therapy vectors for mondependent genes, simultaneously. There are several ways we itoring site-specific delivery and expression of transgenes. can try to reduce the attenuation of the reverse gene and make the system more robust. These include (1) optimization of the number of GAL4-binding sites for two promoters, (2) opti-ACKNOWLEDGMENTS mization of the spacer distance between the genes and the minimal promoter, (3) optimization of the spacer distance between
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BHAUMIK, S., and GAMBHIR, S.S. (2002a). Optical imaging of Re-
Because it is important that any reporter gene-imaging apnilla luciferase reporter gene expression in living mice. Proc. Natil.
proach not significantly perturb the cell or the animal models Acad. Sci. U.S.A. 99. 377-382. being studied we decided to do a dose-response study with var-BHAUMIK, S., and GAMBHIR, S.S. other a ndrogen-independent pathways. The precise role o f A R in clinical situations is n ot fully understood. However, given the fact that AR expression is documented in the majority of HRPC cases (8, 9) and that PSA remains the most reliable marker for recurrent, metastatic prostate cancer (10), it is highly probable the gene regulatory activity of AR is functional in this setting.
Several PSA or probasin promoter-based gene therapy approaches have been developed (11, reviewed in 12). However, thorough investigations questioning the functionality of these AR-dependent therapeutic strategies in HRPC have not been completed.
The current report employs cell-based activity measurements and in vivo molecular imaging to demonstrate that a highly amplified PSA promoter-derived (TSTA) system is active in HRPC models. Non-invasive bioluminescence imaging and Positron Emission Tomography (PET)
illustrate that the prostate-specific TSTA gene expression vectors exhibit robust activity in HRPC as well as androgen dependent tumors. We project that our vector-based gene therapy coupled to molecular imaging would be a promising therapeutic option to develop for treating patients with recurrent disease.
MATERIALS AND METHODS
Adenovirus Constructs.
AdTSTA-FL was constructed as previously described (13, 14) . The AdTSTA-sr39tk
was constructed with the AdEasy system (15) . as described (13, 19) . Immunohistochemistry to detect AR expression in the tumor was performed with anti-AR antibody (Upstate Co, Charlottesville, VA) as previously described (13, 19) . 
RESULTS
The TSTA activity in prostate cancer cell lines
We have developed several transcriptionally-targeted gene expression systems based on t he P SAg ene regulatory regions. The method that e xhibits most potent a ctivity, tissue selectivity and androgen regulation is termed two-step transcriptional activation (TSTA). It employs an enhanced PSA promoter (20) that drives a potent GAL4VP16 synthetic activator, which in turn binds to tandem repeats of GAL4 binding sites to activate the secondary reporter or therapeutic gene. This TSTA method achieved nearly 1000-fold augmentation of activity over the native PSA promoter, and it is more active than the strong viral CMV promoter (14) .
Recently, we have demonstrated that AR in hormone refractory LAPC-9 tumors is functionally active, and it binds to known sites in the PSA gene regulatory region by chromatin immunoprecipitation (13) . Expanding upon this observation, the key objective of this study is to survey the activity of TSTA vectors in a wider array of HRPC models and to visualize the in vivo activity of the vectors by multi-modal molecular imaging techniques.
The activity of the TSTA adenoviral vector (AdTSTA-FL, Figure 1A ) was first determined in two AD lines LNCaP and LAPC-4, and three HRPC lines CWR22Rvl, DU145 and PC-3. As shown in Figure 1B , in the AR-negative DU145 and PC-3 lines AdTSTA-FL activity was n egligible. In the three A R-expressing l ines, the activity of A dTSTA-FL w as stimulated by androgen ranging from 11.4-to 60.6-fold. When bicalutamide (10 ýtM) was given simultaneously in the presence of synthetic androgen R1881 (10 nM), a -50% suppression o f peak activity was observed (data not shown). In the presence of androgen, LNCaP cells exhibited the highest expression, at 4.8 times the level of LAPC-4 and 14.4 foldhigher than CWR22Rvl.
We also investigated the activation in a fourth HRPC line MDA PCa 2b, which interestingly, expresses AR with a double mutation (L701H and T877A) that allows gene expression and growth to become glucocorticoid responsive (21) . As shown in Figure 1C Equivalent gene delivery into the different tumors by intratumoral viral injection was difficult to achieve. Thus, we converted the paired tumors into single cell suspension to examine androgen regulation and the activity of the TSTA system more accurately. In doing so, the dosage of viral vector and androgen administered on a per cell basis can be controlled.
The dispersed tumor cells were infected with AdTSTA-FL in the presence of specified ligands.
AR-protein and androgen-responsive FL activity was observed in both cell populations ( Figure 2C ). In close agreement with the optical imaging results in tumors, we also observed that the activity of AdTSTA-FL is 7.2-fold higher in the hormone refractory (AI) than in AD tumor cells in culture in the presence of 1 nM or higher concentrations of RI 881.
Use of the TSTA vector in PET imaging.
It is important to develop molecular imaging approaches that can be applied in clinical settings for advanced prostate cancer. To this end, we adapted our prostate-specific gene imaging to PET, a radionuclide functional imaging modality that enables 3-D signal
localization. An adenoviral vector that expresses the herpes simplex virus thymidine kinase (HSV-tk) PET reporter gene under the control of TSTA was generated ( Figure 3A ). An Both optical imaging and PET illustrated higher TSTA activity in the hormone refractory xenograft subline versus the parental AD tumor in two models. These findings endorse the idea that activation of AR function occurs despite the castrated level of androgen in vivo. A recent report by Chen et al. (25) showed that 3 to 5-fold elevated expression of AR is a cardinal distinguishing feature between paired AD and hormone refractory tumors. Their work also, supports that AR over-expression can lead to HRPC. In fact, the two models reported here were assessed in the gene expression profiling study (25) . Linking molecular imaging to gene therapy is a favorable method to assess the performance of the intended treatment. In an earlier study, visualization of distant metastases of prostate tumor was accomplished by optical imaging mediated through the use of a modified PSA promoter-based adenoviral vector (19) . Due to the inability of light energy to penetrate deep into tissues, bioluminescence imaging is not applicable in humans. Thus, to translate the above-mentioned promising findings to the clinics, the application of a highenergy clinically-relevant modality such as PET is needed. However, the HSV-tk-based PET imaging is several orders of magnitude less sensitive than optical imaging in small animal studies (30) . The nearly three-order gain in activity of TSTA over native PSA promoter is a key factor to achieve the successful PET imaging of HRPC. Since the same principles are at work in animal microPET as in clinical PET, this result supports the idea of an equivalent gene-based approach in clinical studies.
Many studies have demonstrated that the sr39tk gene can function effectively both as a PET reporter gene as well as a toxic suicide gene (12, 31) . Recently, the AdTSTA-sr39tk was applied in a "one-two punch" imaging and suicide gene therapy to treat prostate tumor 
